Latest Breaking News On - Mast therapeutics - Page 2 : comparemela.com

Savara (NASDAQ:SVRA) Shares Gap Down to $5 07

Savara (NASDAQ:SVRA) Shares Gap Down to $5 07
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerSavara incMast therapeutics incPrincipal financial group incJump financialJennison associatesSavara company profileYork mellon corpSg americas securitiesGet free reportTrading downNew york mellon corpFinancial groupMast therapeuticsSavara daily

Savara s (SVRA) Market Outperform Rating Reaffirmed at JMP Securities

Savara s (SVRA) Market Outperform Rating Reaffirmed at JMP Securities
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Piper sandlerProshare advisorsSusquehanna fundamental investmentsJennison associatesSavara company profileMast therapeutics incSavara incSwiss national bankFree reportGet free reportShare advisorsFundamental investmentsNational bankFinancial marketsMast therapeuticsSavara daily

Savara (NASDAQ:SVRA) Given Market Outperform Rating at JMP Securities

Savara (NASDAQ:SVRA – Get Free Report)‘s stock had its “market outperform” rating reiterated by JMP Securities in a research report issued on Monday, Benzinga reports. They currently have a $8.00 target price on the stock. JMP Securities’ price objective would suggest a potential upside of 64.95% from the company’s current price. Separately, Piper Sandler increased […]

New zealand generalNew zealandPiper sandlerVanguard group incSavara incMast therapeutics incJennison associatesVivo capitalWellington management groupGet free reportCapital partnersMast therapeuticsSavara dailyNasdaq svraReiterated ratingJmp securities

JMP Securities Reiterates Market Outperform Rating for Savara (NASDAQ:SVRA)

Savara (NASDAQ:SVRA – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by JMP Securities in a report issued on Monday, Benzinga reports. They currently have a $8.00 price objective on the stock. JMP Securities’ price target suggests a potential upside of 64.95% from the company’s current price. Separately, Piper Sandler increased their price […]

New zealand generalNew zealandPiper sandlerWellington management groupVivo capitalAffinity asset advisorsJennison associatesSavara incMast therapeutics incGet free reportManagement groupCapital partnersMast therapeuticsSavara daily

Savara (NASDAQ:SVRA) Trading Down 6 5%

Savara Inc (NASDAQ:SVRA – Get Free Report) shares traded down 6.5% during mid-day trading on Thursday . The stock traded as low as $4.62 and last traded at $4.63. 804,305 shares were traded during trading, a decline of 6% from the average session volume of 860,189 shares. The stock had previously closed at $4.95. Wall […]

Piper sandlerSavara incSavara company profilePrincipal financial group incKestra private wealth servicesMast therapeutics incChina universal asset management coTower research capitalGet free reportFinancial groupPrivate wealth servicesUniversal asset managementResearch capitalMast therapeuticsSavara dailyNasdaq svra